'bone marrow stimulation for red blood cell production'

Celginase 10000 Injection belongs to the class of medicines called antineoplastic (anticancer) agents used in the treatment of acute lymphoblastic leukaemia (a type of blood and bone marrow cancer). Acute lymphoblastic leukaemia (ALL) is the most common childhood cancer. It is a type of blood cancer which causes excessive production of lymphocytes (a type of white blood cells) by the bone marrow. Celginase 10000 Injection contains L Asparaginase which works by lowering asparagine levels in the body, which is necessary for the survival of cancer cells. Thus, Celginase 10000 Injection stops the cancer cells from dividing and growing. Celginase 10000 Injection will be administered by a healthcare professional; do not self-administer. Sometimes, Celginase 10000 Injection may cause common side effects such as nausea, weight loss, generalised pain or muscle pain, infections or a decrease in normal blood content. Most of these side effects of Celginase 10000 Injection do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. If you are allergic to L asparaginase or other medicines, please tell your doctor. You are recommended to avoid breastfeeding during treatment with Celginase 10000 Injection as there may be a risk to the feeding child. If you are pregnant or planning pregnancy, please inform your doctor before receiving Celginase 10000 Injection. Also, you are recommended to use effective contraceptive methods before and for at least 3 months after treatment with Celginase 10000 Injection to prevent pregnancy. Celginase 10000 Injection is given to children in doses as advised by the doctor, depending on the age. Avoid driving after receiving Celginase 10000 Injection as it may cause drowsiness or dizziness.

DARCEPT 40MG INJECTION belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). DARCEPT 40MG INJECTION helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. DARCEPT 40MG INJECTION contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. DARCEPT 40MG INJECTION is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, DARCEPT 40MG INJECTION stimulates the production of this protein in the bone marrow. DARCEPT 40MG INJECTION will be injected by the healthcare provider. Do not self-administer. The most common side effects of DARCEPT 40MG INJECTION are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of DARCEPT 40MG INJECTION do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Erypeg 100mcg Injection is a medicine used in the treatment of anemia due to chronic kidney disease and cancer chemotherapy. It works by stimulating the stem cells of the bone marrow to increase red blood cell production. At the same time, it acts on red blood cells to protect them against destruction. Erypeg 100mcg Injection is generally given by a doctor or a nurse. Do not self-administer this medicine at home. The dose depends on your body weight and the cause of your anemia. Get the injection regularly until you complete the dose. Iron supplements both before and during treatment may make this treatment more effective. The most common side effects of taking this medicine include nausea, vomiting, diarrhea, and fever. It may also cause other side effects. These side effects are most common at the start of treatment but if they persist your doctor may be able to suggest ways of preventing or reducing them.

Erypeg 50mcg Injection is a medicine used in the treatment of anemia due to chronic kidney disease and cancer chemotherapy. It works by stimulating the stem cells of the bone marrow to increase red blood cell production. At the same time, it acts on red blood cells to protect them against destruction. Erypeg 50mcg Injection is generally given by a doctor or a nurse. Do not self-administer this medicine at home. The dose depends on your body weight and the cause of your anemia. Get the injection regularly until you complete the dose. Iron supplements both before and during treatment may make this treatment more effective. The most common side effects of taking this medicine include nausea, vomiting, diarrhea, and fever. It may also cause other side effects. These side effects are most common at the start of treatment but if they persist your doctor may be able to suggest ways of preventing or reducing them.

Erypeg 75mcg Injection is a medicine used in the treatment of anemia due to chronic kidney disease and cancer chemotherapy. It works by stimulating the stem cells of the bone marrow to increase red blood cell production. At the same time, it acts on red blood cells to protect them against destruction. Erypeg 75mcg Injection is generally given by a doctor or a nurse. Do not self-administer this medicine at home. The dose depends on your body weight and the cause of your anemia. Get the injection regularly until you complete the dose. Iron supplements both before and during treatment may make this treatment more effective. The most common side effects of taking this medicine include nausea, vomiting, diarrhea, and fever. It may also cause other side effects. These side effects are most common at the start of treatment but if they persist your doctor may be able to suggest ways of preventing or reducing them.

Erypeg 30 Injection is a medicine used in the treatment of anemia due to chronic kidney disease and cancer chemotherapy. It works by stimulating the stem cells of the bone marrow to increase red blood cell production. At the same time, it acts on red blood cells to protect them against destruction. Erypeg 30 Injection is generally given by a doctor or a nurse. Do not self-administer this medicine at home. The dose depends on your body weight and the cause of your anemia. Get the injection regularly until you complete the dose. Iron supplements both before and during treatment may make this treatment more effective. The most common side effects of taking this medicine include nausea, vomiting, diarrhea, and fever. It may also cause other side effects. These side effects are most common at the start of treatment but if they persist your doctor may be able to suggest ways of preventing or reducing them.

Zynesp 200 mcg Injection belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). Zynesp 200 mcg Injection helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. Zynesp 200 mcg Injection contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. Zynesp 200 mcg Injection is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, Zynesp 200 mcg Injection stimulates the production of this protein in the bone marrow. Zynesp 200 mcg Injection will be injected by the healthcare provider. Do not self-administer. The most common side effects of Zynesp 200 mcg Injection are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of Zynesp 200 mcg Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to darbepoetin alfa or epoetin alfa, please inform your doctor before taking Zynesp 200 mcg Injection to avoid any complications. Also, mention all the other medications you are taking to affect the way Zynesp 200 mcg Injection works. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be signs that the body has stopped responding to Zynesp 200 mcg Injection .

Primary Uses: Anemia due to Chronic Kidney Disease (CKD): In CKD, the kidneys produce less erythropoietin, leading to decreased red blood cell production. Actorise 100 Injection helps stimulate the bone marrow to produce more red blood cells, thereby improving oxygen delivery and reducing symptoms like fatigue and weakness.​ Anemia due to Cancer Chemotherapy: Chemotherapy can suppress bone marrow function, leading to decreased red blood cell production. Actorise 100 Injection helps stimulate red blood cell production, mitigating anemia and its associated symptoms in cancer patients undergoing chemotherapy.​ 💉 How It Works: Darbepoetin alfa is a synthetic form of erythropoietin. By binding to erythropoietin receptors in the bone marrow, it promotes the proliferation and differentiation of red blood cell precursors, leading to increased red blood cell production.​

Primary Uses: Anemia due to Chronic Kidney Disease (CKD): In CKD, the kidneys produce less erythropoietin, leading to decreased red blood cell production. Actorise 200 Injection helps stimulate the bone marrow to produce more red blood cells, thereby improving oxygen delivery and reducing symptoms like fatigue and weakness.​ Pilcare Anemia due to Cancer Chemotherapy: Chemotherapy can suppress bone marrow function, leading to decreased red blood cell production. Actorise 200 Injection helps stimulate red blood cell production, mitigating anemia and its associated symptoms in cancer patients undergoing chemotherapy.​ 💉 How It Works: Darbepoetin alfa is a synthetic form of erythropoietin. By binding to erythropoietin receptors in the bone marrow, it promotes the proliferation and differentiation of red blood cell precursors, leading to increased red blood cell production.​ ⚠️ Important Considerations: Administration: Actorise 200 Injection is administered under the supervision of a healthcare professional, either subcutaneously (under the skin) or intravenously (into a vein).​ Storage: Store the injection in a refrigerator at 2–8°C. Do not freeze. Protect from light.​ Monitoring: Regular monitoring of hemoglobin levels and blood pressure is essential during treatment.​ Contraindications: Not recommended for individuals with uncontrolled hypertension, a history of pure red cell aplasia, or known hypersensitivity to darbepoetin alfa or any of its components.​